NDA urged to register sickle cell drug

Simple item page
dc.contributor.authorMagezi, N Lilian
dc.contributor.authorManishimwe, Wilson
dc.date.accessioned2026-05-15T08:26:05Z
dc.date.available2026-05-15T08:26:05Z
dc.date.issued2018-03-05
dc.descriptionNews article
dc.description.abstractStatistics show that every year, about 20,000 children with sickle cell disease are born in Uganda. However, 80% of them die under the age of five. Therefore the health minister has directed NDA to register a drug used in the treatment of sickle cell disease.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/2669
dc.language.isoen
dc.publisherNew Vision
dc.titleNDA urged to register sickle cell drug
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
lilian n magezi and Wilson manishimwe NV 5mar2018 .pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences